【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Post-Operative Pain Overview 11
Therapeutics Development 12
Pipeline Products for Post-Operative Pain – Overview 12
Pipeline Products for Post-Operative Pain – Comparative Analysis 13
Post-Operative Pain – Therapeutics under Development by Companies 14
Post-Operative Pain – Therapeutics under Investigation by Universities/Institutes 17
Post-Operative Pain – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Post-Operative Pain – Products under Development by Companies 21
Post-Operative Pain – Products under Investigation by Universities/Institutes 23
Post-Operative Pain – Companies Involved in Therapeutics Development 24
A. Menarini Industrie Farmaceutiche Riunite Srl 24
AcelRx Pharmaceuticals, Inc. 25
Adynxx, Inc. 26
AngioChem Inc. 27
Boehringer Ingelheim GmbH 28
Cara Therapeutics, Inc. 29
Chong Kun Dang Pharmaceutical Corp. 30
Cytogel Pharma, LLC 31
DURECT Corporation 32
Echo Pharmaceuticals B.V. 33
Encore Therapeutics Inc. 34
Flexion Therapeutics, Inc. 35
Galleon Pharmaceuticals 36
Grunenthal GmbH 37
GW Pharmaceuticals plc 38
Heron Therapeutics, Inc. 39
Immupharma Plc 40
INSYS Therapeutics, Inc. 41
Laboratorios Del Dr. Esteve S.A. 42
Medtronic, Inc. 43
Ocular Therapeutix, Inc. 44
Omeros Corporation 45
Orbis Biosciences, Inc. 46
Orion Oyj 47
Pharmazz, Inc. 48
PhytoHealth Corporation 49
Recro Pharma, Inc. 50
Rottapharm SpA 51
Takeda Pharmaceutical Company Limited 52
Thar Pharmaceuticals, Inc. 53
Trevena, Inc. 54
UMeWorld Limited 55
Post-Operative Pain – Therapeutics Assessment 56
Assessment by Monotherapy Products 56
Assessment by Combination Products 57
Assessment by Target 58
Assessment by Mechanism of Action 60
Assessment by Route of Administration 62
Assessment by Molecule Type 64
Drug Profiles 66
(bupivacaine hydrochloride + meloxicam) – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
(dexketoprofen trometamol + tramadol hydrochloride) – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
(ketoprofen + amitriptyline + oxymetazoline) – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
(ketorolac tromethamine + phenylephrine hydrochloride) – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
AM-4 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
ANG-2002 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
ARX-01 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
ARX-8028 – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
ARX-8203 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
AYX-1 – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
BI-1026706 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
bupivacaine hydrochloride – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
bupivacaine hydrochloride liposomal – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
bupivacaine hydrochloride SR – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
buprenorphine hydrochloride – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
centhaquine – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
CKD-943 – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
CMX-020 – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
CR-4056 – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
CR-845 – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
Cyt-1010 – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
dexamethasone acetate SR – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
dexmedetomidine hydrochloride – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
dronabinol – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
E-52862 – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
fadolmidine hydrochloride – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
FX-007 – Drug Profile 106
Product Description 106
Mechanism of Action 106
R&D Progress 106
GAL-044 – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
GIBH-1014 – Drug Profile 108
Product Description 108
Mechanism of Action 108
R&D Progress 108
grapiprant – Drug Profile 109
Product Description 109
Mechanism of Action 109
R&D Progress 109
IPP-102199 – Drug Profile 111
Product Description 111
Mechanism of Action 111
R&D Progress 111
ketamine hydrochloride ER – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
MDT-10013 – Drug Profile 113
Product Description 113
Mechanism of Action 113
R&D Progress 113
nabiximols – Drug Profile 114
Product Description 114
Mechanism of Action 114
R&D Progress 114
nalbuphine hydrochloride – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
ropivacaine – Drug Profile 118
Product Description 118
Mechanism of Action 118
R&D Progress 118
ropivacaine ER – Drug Profile 119
Product Description 119
Mechanism of Action 119
R&D Progress 119
T-109 – Drug Profile 121
Product Description 121
Mechanism of Action 121
R&D Progress 121
tapentadol hydrochloride – Drug Profile 122
Product Description 122
Mechanism of Action 122
R&D Progress 122
tramadol hydrochloride – Drug Profile 123
Product Description 123
Mechanism of Action 123
R&D Progress 123
TRV-130 – Drug Profile 124
Product Description 124
Mechanism of Action 124
R&D Progress 124
VVZ-149 – Drug Profile 125
Product Description 125
Mechanism of Action 125
R&D Progress 125
Post-Operative Pain – Recent Pipeline Updates 126
Post-Operative Pain – Dormant Projects 153
Post-Operative Pain – Discontinued Products 155
Post-Operative Pain – Product Development Milestones 156
Featured News & Press Releases 156
Nov 17, 2014: Trevena Announces Positive Top-Line Results from Phase 2a/b Study of TRV130 in Acute Postoperative Pain 156
Oct 30, 2014: Omidria Granted Pass-Through Reimbursement Status from CMS 158
Oct 08, 2014: Ocular Therapeutix Completes Enrollment in Phase 3 Sustained Release Dexamethasone Trials for Post-Operative Inflammation and Pain 158
Oct 08, 2014: Trevena Announces Early Completion of Enrollment of Phase 2a/b Study of TRV130 in Postoperative Pain 159
Sep 16, 2014: Trevena Granted Key U.S. Composition of Matter Patent for TRV130 159
Sep 04, 2014: Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN 159
Jul 16, 2014: Adynxx Initiates Phase 2 Dose-Ranging Study of AYX1, Lead Compound for the Prevention of Post-Surgical Pain 160
May 14, 2014: Heron Therapeutics Reports Positive Results for Post-Surgical Pain Program 161
May 02, 2014: Trevena Presents Results from Phase 1b Trial of Injectable Analgesic TRV130 at American Society of Pain Annual Meeting 161
May 01, 2014: Trevena Initiates Phase 2 Study of TRV130 in Acute Postoperative Pain 162
Appendix 164
Methodology 164
Coverage 164
Secondary Research 164
Primary Research 164
Expert Panel Validation 164
Contact Us 165
Disclaimer 165
【レポート販売概要】
■ タイトル:術後疼痛(Post-Operative Pain)の治療薬パイプライン動向(2015年上半期版)■ 英文:Post-Operative Pain - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6116IDB
■ 調査対象地域:グローバル
- グローバルヘアケア製品市場におけるM&A動向(2014年3月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global haircare market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global haircare market throughout the month. Additionally, the report provides an overview of all the partneri …
- 広報(PR)ツールの世界市場分析:産業別(BFSI、小売、政府、ヘルスケア、ITおよびテレコム、メディアおよびエンターテイメント)、ソリューション別、用途別、展開別(ホスティングとオンプレミス)、地域別、セグメント予測、2014 – 2024The global public relations (PR) tools market is estimated to reach USD 12.99 billion by 2024, according to a new report by Grand View Research, Inc. The recent years have seen a considerable change in the public relations landscape as it has taken the center stage in the marketing activities of organizations. There has been an increasing number of efforts at quantifying the impact of public relat …
- 本態性血小板血症(Essential Thrombocythemia):治療薬開発パイプライン動向(2015年上半期版)Essential Thrombocythemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H1 2015’, provides an overview of the Essential Thrombocythemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Essential Thrombocythemia, complete with comparative analysis at various stages, therapeutics asse …
- 世界のPrepared Meals市場におけるニュース・イベント動向(2014年2月)Synopsis The report provides a review of the latest news and key events in the global prepared meals market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global prepared meals market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in …
- 世界のスマートメーター市場動向n/a
- ペンニードルの世界市場:種類、長さ、治療、購入、地域別分析The pen needles market is expected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% from 2016 to 2021. The market is segmented on the basis of type, needle length, therapy, and mode of purchase. By type, the market is categorized into standard and safety pen needles. The standard pen needles segment is expected to account for the largest share of the mark …
- 世界の無線ネットワークセキュリティ市場動向(2014-2019)Today, enterprises are relying more and more on wireless networks. There is no doubt that the wireless networking infrastructure has helped organizations to cut maintenance costs and increase the operating income. Although it looks good from the point of view of profitability, it also makes these organizations an easy target of cyber criminals. Wireless networks no doubt have their perks, but they …
- Mコマースの世界市場2015-2019About m-Commerce Mobile commerce or m-commerce, as it is widely called, is the buying or selling of goods over a mobile-enabled platform. The West, in particular, has been very proactive in adopting this platform to improve commercial transactions. The high adoption of this platform has enabled various retail stores to go online, and adopt more effective marketing strategies. With the proliferatio …
- VRカードボードの世界市場2015-2019About VR cardboard VR cardboard which is also known by terms such as Google Cardboard and VR headsets are devices that act as a mount for smartphones and tablets. It is a platform developed by Google that provides downloadable instructions to individuals and manufacturers for building VR headsets. The name suggests that the headset can be built out of cardboard, but does not necessarily mean that …
- The 2011 Ultimate Guide to Location Based Services and ApplicationsLocation-Based Services, often referred to as LBS, use information transmitted from a device to determine its presence and location. Terminals can be fixed or mobile; both receive and transmit data. They include, but are not limited to, wireless phones, laptops, portable navigation devices, and embedded systems. Amassed with location identification are a host of functions ranging from marketing an …
- 世界の髄核置換装置市場:医療機器パイプライン分析2016Nucleus Replacement - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Nucleus Replacement - Medical Devices Pipeline Assessment, 2016" provides an overview of Nucleus Replacement currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development …
- ハラル化粧品の世界市場分析:製品別(スキンケア、ヘアケア、メイク)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ)、競争戦略、セグメント予測、2014-2025The global halal cosmetics market is expected to reach USD 52.02 billion by 2025, according to a new report by Grand View Research, Inc. Awareness levels of Muslim populace regarding the ingredients used in cosmetic and personal care formulations to determine the industry’s future growth trajectory. With considerable Islamic population and their ingraining of cultural aspects into daily lifestyles …
- 短波長赤外線(SWIR)の世界市場:テルル化水銀カドミウム、砒化インジウムガリウム、硫化鉛、アンチモン化インジウムThe global Short Wave Infrared (SWIR) market is expected to grow from USD 66.5 Million in 2015 to USD 118.9 Million by 2022, at a CAGR of 8.6% from 2016 to 2022. The major drivers for the global Short Wave Infrared (SWIR) market are technological development of shortwave IR detector in terms of size, weight, and power at low cost as well as the night sighting capabilities for military application. …
- 物理蒸着(PVD)の世界市場分析:種類別(PVD装置、PVD材質、PVDサービス)、用途別(マイクロエレクトロニクス、データストレージ、太陽光発電製品、切削工具、医療機器)、セグメント予測The global physical vapor deposition (PVD) market is expected to reach USD 31.63 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for thin film coatings from microelectronics and solar products is expected to drive demand. Moreover, an increasing number of end-use industry players are projected to drive the PVD market over the forecast period. Also, advance …
- エチレン酢酸ビニル(EVA)の世界市場予測Ethylene-vinyl acetate 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about ethylene-vinyl acetate market in the all-in-one report issued in a logical and easily accessible format. In addition to …